Kadimastem (Israel) Buy Hold or Sell Recommendation

KDST Stock  ILA 485.00  35.00  6.73%   
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Kadimastem is 'Strong Sell'. Macroaxis provides Kadimastem buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding KDST positions. The advice algorithm takes into account all of Kadimastem's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Kadimastem's buy or sell advice are summarized below:
Real Value
437.72
Hype Value
485
Market Value
485
Naive Value
495.42
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Kadimastem given historical horizon and risk tolerance towards Kadimastem. When Macroaxis issues a 'buy' or 'sell' recommendation for Kadimastem, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Kadimastem Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Kadimastem and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Kadimastem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Execute Kadimastem Buy or Sell Advice

The Kadimastem recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Kadimastem. Macroaxis does not own or have any residual interests in Kadimastem or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Kadimastem's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell KadimastemBuy Kadimastem
Strong Sell

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

Below AverageDetails

Economic Sensitivity

Almost neglects market trendsDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Kadimastem has a Mean Deviation of 3.07, Standard Deviation of 4.36 and Variance of 19.03
Macroaxis provides trade recommendations on Kadimastem to complement and cross-verify current analyst consensus on Kadimastem. Our advice engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Kadimastem is not overpriced, please verify all Kadimastem fundamentals, including its shares outstanding, shares owned by institutions, price to book, as well as the relationship between the shares owned by insiders and price to earning .

Kadimastem Trading Alerts and Improvement Suggestions

Kadimastem generated a negative expected return over the last 90 days
Kadimastem has high historical volatility and very poor performance
The company has accumulated 12.96 M in total debt with debt to equity ratio (D/E) of 7.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Kadimastem has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Kadimastem until it has trouble settling it off, either with new capital or with free cash flow. So, Kadimastem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Kadimastem sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Kadimastem to invest in growth at high rates of return. When we think about Kadimastem's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (26.27 M) with profit before overhead, payroll, taxes, and interest of 0.
Kadimastem has accumulated about 5.43 M in cash with (21.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28.
Roughly 54.0% of Kadimastem outstanding shares are owned by corporate insiders

Kadimastem Returns Distribution Density

The distribution of Kadimastem's historical returns is an attempt to chart the uncertainty of Kadimastem's future price movements. The chart of the probability distribution of Kadimastem daily returns describes the distribution of returns around its average expected value. We use Kadimastem price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Kadimastem returns is essential to provide solid investment advice for Kadimastem.
Mean Return
-0.29
Value At Risk
-6.22
Potential Upside
5.56
Standard Deviation
4.36
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Kadimastem historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Kadimastem Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Kadimastem or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Kadimastem's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Kadimastem stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-0.27
β
Beta against NYSE Composite-0.4
σ
Overall volatility
4.76
Ir
Information ratio -0.09

Kadimastem Volatility Alert

Kadimastem exhibits very low volatility with skewness of 1.61 and kurtosis of 7.1. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Kadimastem's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Kadimastem's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Kadimastem Fundamentals Vs Peers

Comparing Kadimastem's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Kadimastem's direct or indirect competition across all of the common fundamentals between Kadimastem and the related equities. This way, we can detect undervalued stocks with similar characteristics as Kadimastem or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Kadimastem's fundamental indicators could also be used in its relative valuation, which is a method of valuing Kadimastem by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Kadimastem to competition
FundamentalsKadimastemPeer Average
Return On Equity-7.35-0.31
Return On Asset-0.75-0.14
Current Valuation38.77 M16.62 B
Shares Outstanding35.76 M571.82 M
Shares Owned By Insiders53.72 %10.09 %
Shares Owned By Institutions8.31 %39.21 %
Price To Earning(167.60) X28.72 X
Price To Book5.90 X9.51 X
EBITDA(24.48 M)3.9 B
Net Income(26.27 M)570.98 M
Cash And Equivalents5.43 M2.7 B
Cash Per Share0.28 X5.01 X
Total Debt12.96 M5.32 B
Debt To Equity7.80 %48.70 %
Current Ratio0.39 X2.16 X
Book Value Per Share0.23 X1.93 K
Cash Flow From Operations(21.55 M)971.22 M
Earnings Per Share(1.11) X3.12 X
Number Of Employees2318.84 K
Beta0.69-0.15
Market Capitalization30.32 M19.03 B
Total Asset27.34 M29.47 B
Retained Earnings(88 M)9.33 B
Working Capital(6 M)1.48 B
Current Asset5 M9.34 B
Current Liabilities11 M7.9 B
Z Score-3.08.72
Net Asset27.34 M

Kadimastem Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Kadimastem . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Kadimastem Buy or Sell Advice

When is the right time to buy or sell Kadimastem? Buying financial instruments such as Kadimastem Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Kadimastem in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Natural Foods Thematic Idea Now

Natural Foods
Natural Foods Theme
Companies producing natural foods including dairy products and different types of meets. The Natural Foods theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Natural Foods Theme or any other thematic opportunities.
View All  Next Launch
Check out Kadimastem Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Kadimastem Stock analysis

When running Kadimastem's price analysis, check to measure Kadimastem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kadimastem is operating at the current time. Most of Kadimastem's value examination focuses on studying past and present price action to predict the probability of Kadimastem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kadimastem's price. Additionally, you may evaluate how the addition of Kadimastem to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Please note, there is a significant difference between Kadimastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kadimastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kadimastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.